Many scientists have criticized the FDA for approving Aduhelm, a costly Alzheimer’s drug that may not do much to slow the disease. But a patient taking the drug says it has given him hope.
With Product You Purchase
Subscribe to our mailing list to get the new updates!
6 seconds ago
2 hours ago
4 hours ago